SelexipagPharm Company: * MSN LABORATORIES PRIVATE LTD
Category: Blood Pressure
Selexipag, sold under the brand name Uptravi, is a medication developed by Actelion for the treatment of pulmonary arterial hypertension (PAH). Selexipag and its active metabolite, ACT-333679 (or MRE-269, the free carboxylic acid), are agonists of the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. It is taken by mouth or administered intravenously. Contents 1 Contraindications 2 Adv... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.